Cite Filings / CNSY / 0001086364-12-002016
Feed Companies Filings Check
Sign in
SC 13G/A

Amended Statement of Ownership

CERENOME, INC. · Filed 2012-02-13 · Acc 0001086364-12-002016

Documents 1

  • SC 13G/A Amended Statement of Ownership , cytori.therapeutics.inc..txt

Around this filing

  • 2013-02-08 SC 13G/A Amended Statement of Ownership
  • 2012-02-13 SC 13G/A Amended Statement of Ownership
  • 2012-02-06 4 Chief Executive Officer sold 205,000 shares at an average $4.02 ($824,483)
  • 2011-02-14 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-05-15 SCHEDULE 13G/A · CVI Investments, Inc. 4.9%
  2. 2026-05-15 SCHEDULE 13G · Highbridge Capital Management, LLC 7.1%
  3. 2026-01-22 SCHEDULE 13G · CVI Investments, Inc. 6.9%
  4. 2025-08-14 SCHEDULE 13G/A · S.H.N. Financial Investments Ltd. 1.51%
  5. 2025-07-29 SCHEDULE 13G/A · Orin Hirschman 3.9%
  6. 2025-06-25 SCHEDULE 13G/A · The Hewlett Fund LP 0%
  7. 2025-05-22 SCHEDULE 13G · The Hewlett Fund LP 8.255%
  8. 2025-03-18 SCHEDULE 13G · S.H.N. Financial Investments Ltd. 9.99%
  9. 2025-02-10 SCHEDULE 13G/A · Orin Hirschman 9.5%
  10. 2024-06-05 SC 13G · AIGH Capital Management, LLC 9.9%
  11. 2002-02-25 SC 13G · Christopher J. Calhoun 5.7%
  12. 2002-02-11 SC 13G · Medtronic, Inc. 6.6%
Loading cytori.therapeutics.inc..txt…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…